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Abstract
Background: The transcription factor c-myc regulates genes involved in hepatocyte growth, proliferation,
metabolism, and differentiation. It has also been assigned roles in liver development and regeneration. In previous
studies, we made the unexpected observation that c-Myc protein levels were similar in proliferating fetal liver and
quiescent adult liver with c-Myc displaying nucleolar localization in the latter. In order to investigate the functional
role of c-Myc in adult liver, we have developed a hepatocyte-specific c-myc knockout mouse, c-myc
fl/fl;Alb-Cre.
Results: Liver weight to body weight ratios were similar in control and c-myc deficient mice. Liver architecture was
unaffected. Conditional c-myc deletion did not result in compensatory induction of other myc family members or
in c-Myc’s binding partner Max. Floxed c-myc did have a negative effect on Alb-Cre expression at 4 weeks of age.
To explore this relationship further, we used the Rosa26 reporter line to assay Cre activity in the c-myc floxed mice.
No significant difference in Alb-Cre activity was found between control and c-myc
fl/fl mice. c-myc deficient mice
were studied in a nonproliferative model of liver growth, fasting for 48 hr followed by a 24 hr refeeding period.
Fasting resulted in a decrease in liver mass and liver protein, both of which recovered upon 24 h of refeeding in
the c-myc
fl/fl;Alb-Cre animals. There was also no effect of reducing c-myc on recovery of liver mass following 2/3
partial hepatectomy.
Conclusions: c-Myc appears to be dispensable for normal liver growth during the postnatal period, restoration of
liver mass following partial hepatectomy and recovery from fasting.
Background
The Myc family includes three closely related genes, c-
myc, L-myc, and N-myc, which have been shown to have
similar biological activities. The three Myc proteins are
basic helix-loop-helix leucine zipper transcription factors
that heterodimerize with a binding partner, Max, to
bind DNA and either activate or repress the transcrip-
tion of a large set of target genes [1-3]. An additional
member of the family, B-myc, encodes a protein that is
homologous to the N-terminal domain of c-Myc, but its
function remains largely unknown [4]. c-Myc has been
shown to regulate genes involved in ribosomal biogen-
esis, protein translation and the transition from the G0/
G1 to S-phase of the cell cycle suggesting that c-Myc
has a functional role in the coordination of cellular
growth and proliferation. The expression of c-myc is, in
general, tightly regulated. Proliferating cells contain high
levels of this protein, while the level of c-Myc is signifi-
cantly decreased as cells growth arrest and differentiate
[3]. Dysregulated expression of c-myc is associated with
the development of many tumors in rodents and
humans, including hepatocellular carcinoma [5-7].
c-Myc has been implicated as a regulator of hepato-
cyte proliferation, growth and metabolism [8,9]. During
the process of liver regeneration, quiescent hepatocytes
synchronously enter the cell cycle and undergo one, two
or more rounds of replication to restore liver mass [10].
Considered an immediate early gene, c-myc expression
is induced within 30 minutes following partial hepatect-
omy and has been suggested to be a key factor in the
transcriptional response leading to the progression of
hepatocytes from G0/G1 to S phase [11]. Transient
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tocyte enlargement and induction of ribosomal and
nucleolar genes [12]. Other studies involving c-myc
transgenic mice have shown that overexpression of c-
Myc in the liver induces hepatic glucose uptake and uti-
lization and can inhibit gluconeogenesis [13,14]. While
these studies support a role for c-Myc in hepatocyte
growth, ribosomal biogenesis and metabolism, they do
not address whether c-Myc is required or whether the
effects on these processes were due to superphysiologi-
cal levels of c-Myc.
Previous studies from our laboratory on the regulation
of c-Myc during rat liver development revealed several
novel findings. First, in contrast to many other organ
systems and cell types, rapidly proliferating fetal and
quiescent adult liver contained similar levels of c-Myc
protein. In adult hepatocytes, c-Myc was localized to the
nucleolus, while fetal hepatocytes displayed diffuse
nuclear localization. In addition, c-Myc translocated out
of the nucleolus in response to a partial hepatectomy
[15,16]. These data led us to hypothesize that hepatic c-
Myc may play a functional role in liver other than its
well established role in hepatocyte proliferation. In
order to examine the function of c-Myc in adult liver,
we mated mice in which the c-myc locus was floxed to
mice expressing Cre recombinase under the control of
the albumin promoter. The present paper describes the
characterization of these mice.
Methods
Animals
c-myc
fl/fl mice were gifts of I. Moreno de Alboran [17].
Alb-Cre and ROSA26 mice were obtained from Jackson
Laboratories (Bar Harbor, ME [18,19]). All mice were
C57BL/6 strain housed in a pathogen-free facility and
maintained on a 12 hr light/dark cycle. c-myc
fl/fl mice
were mated to Alb-Cre mice to achieve mice that car-
ried a floxed c-myc allele and Alb-Cre. Littermates were
bred to obtain c-myc
fl/fl;Alb-Cre
+ mice and the control
mice (c-myc
fl/fl;Alb-Cre
-/-, c-myc
+/+;Alb-Cre
+). Progeny
were mated to obtain c-myc
fl/fl;Alb-Cre
+/+ mice and the
control c-myc
+/+;Alb-Cre
+/+ mice. Breeding pairs that
produced litters consisting exclusively of Cre
+ pups for
at least 5 successive matings were considered Cre
+/+. c-
myc
fl/fl;Alb-Cre
+/+ and the control c-myc
+/+;Alb-Cre
+/+
lines were established from these pairs. Pups from both
sexes were used for all analyses except 2/3 partial hepa-
tectomy. Blood glucose concentrations were determined
using a YSI 2300 STAT plus glucose and lactate analy-
zer (YSI Life Sciences; Yellow Springs, OH).
For fasting and refeeding experiments, eight week old
male and female c-myc
fl/fl and c-myc
+/+;Alb-Cre expres-
sing mice were fed standard rodent chow ad libitum
(control) or fasted for 48 hr. Where noted, standard
rodent chow was replaced in the cage covers and ani-
mals were allowed to feed ad libitum f o r2 4h r( r e f e d ) .
Water was freely available to all mice. Eight to ten week
old male c-myc
fl/fl and c-myc
+/+ Alb-Cre expressing mice
were anesthetized using isoflurane and subjected to 2/3
partial hepatectomy as described by Higgins and Ander-
son [20]. All mice were killed by exsanguination under
isoflurane anesthesia. Carcass and liver weights were
recorded. The liver was divided and fixed in 10% neutral
buffered formalin or flash frozen in liquid nitrogen
before being stored at -70°C.
To assess Cre activity, female c-myc
fl/fl;Alb-Cre
+/+ and
c-myc
+/+;Alb-Cre
+/+ were crossed with male ROSA26
mice. Mice were further mated to obtain the following
genotypes used for study, c-myc
fl/fl;Alb-Cre
+;ROSA26
+
and c-myc
+/+;Alb-Cre
+;ROSA26
+. Mice were genotyped
using PCR analysis of tail genomic DNA according to
published protocols for c-myc [21], Alb-Cre transgene
[22] and the ROSA26 alleles http://jaxmice.jax.org/pro-
tocolsdb/f?p=116:1:3259541732707236::NO:::.
All experiments on mice were performed in accor-
dance with the guidelines of the National Institutes of
Health and the Rhode Island Hospital Institutional Ani-
mal Care and Use Committee.
DNA Isolation and qPCR
DNA was isolated from triplicate frozen livers obtained
from c-myc
fl/fl;Alb-Cre
-/-, c-myc
fl/fl;Alb-Cre
± and c-myc
fl/
fl;Alb-Cre
+/+ mice at 4, 8, and 10 weeks of age using the
DNeasy kit (Qiagen; Valenci a ,C A ) .q P C Rr e a c t i o n s
were performed in triplicate using 25 ng of DNA, 23 μl
SYBR green reaction mix, and the 7500 Real-Time PCR
system (Applied Biosystems; F o s t e rC i t y ,C A ) .I no r d e r
to detect the deletion of the c-myc
fl allele, primers were
designed upstream of the 5’ lox P site (primers X and
Y) and on either side of the 3’ lox P site (NB). The pri-
mer sequences are as follows: primer X, 5’-CCTC
GCGCCCCTGAA-3’;p r i m e rY ,5 ’-AACCGCTCAGAT
CACGACTCA-3’;p r i m e rN ,5 ’-TCCAAACCAGA
AACTGAAACATGT-3’; primer B, 5’-ACAATGGGGTC
ATTTAGGAC-3’. The relative abundance of the c-myc
fl
allele was calculated by the comparative CT method
using the product generated by primers X and Y as the
reference. c-myc deletion during liver regeneration was
assessed by calculating the ddCt (dCt in liver removed
at the time of hepatectomy– minus the dCt in regener-
ating liver from the same animal) for triplicate mice.
RNase protection assay
Total RNA was isolated from triplicate frozen livers
obtained from 8 and 10 week old c-myc
+/+ and c-myc
fl/fl
Alb-Cre expressing mice as previously described [15].
RNase protection assays were performed using the
mMyc multiprobe template with yeast tRNA as a
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was used as an internal control to normalize expression
data. Quantification of bands was performed by digital
analysis using LabWorks software (UVP; Upland, CA).
RT-qPCR
Total RNA was isolated from frozen livers obtained
from 4, 8, and 10 week old control (c-myc
fl/fl;Alb-Cre
-/-
and c-myc
+/+;Alb-Cre) and c-myc
fl/fl;Alb-Cre mice using
the RiboPure Kit (Ambion; Foster City, CA). RNA was
cleaned using the RNeasy kit (Qiagen) and cDNA
synthesized using random hexamers and the TaqMan
Reverse Transcription kit (Applied Biosystems). Primer
sequences used for amplification of cre were 5’-CGATG
CAACGAGTGATGAGG-3’ for the sense primer and 5’-
GGCAAACGGACAGAAGCATT-3’ for the antisense
primer. Mouse c-myc primers were obtained from
SABiosciences (Frederick, MD). The internal standard
GAPDH was amplified using the following primer
sequences, 5’-TCCAGTATGACTCCACTCACGG-3’
and 5’-TCGCTCCTGGAAGATGGTG-3’.T h er e l a t i v e
abundance of cre and c-myc was calculated by the com-
parative CT method using GAPDH as the reference.
Histology and image analysis
Liver was fixed in 10% neutral buffered formalin, paraf-
fin embedded, and stained with hemotoxylin and eosin.
Immunohistochemistry was performed for Ki-67 using
the indirect immuneperoxidase technique. Briefly, sec-
tions were deparaffinized and microwaved in 100 mM
sodium citrate buffer, pH 6.0 for 20 minutes, followed
by incubation in anti-Ki-67 antibody (Abcam, Cam-
bridge, MA) overnight at 4°C. Slides were scanned with
an Aperio Scanscope CS (Aperio Technologies, Inc.,
Vista, CA). Ki-67 positive cells in ten 20× fields were
counted. For Lac-Z staining, liver cryosections (10 μm)
were fixed in phosphate buffered saline, pH 7.3 (140
mM NaCl; 2.7 mM KCl; 8.1 mM Na2HPO4;1 . 5m M
KH2PO4) containing 0.2% gluteraldehyde, 10 mM
EGTA, and 2 mM MgCl2. Sections were washed three
times with phosphate buffered saline containing 0.05
mM EGTA, 2 mM MgCl2, 0.12 mM Na deoxycolate,
and 0.02% Nonidet P-40 and incubated overnight in the
same solution containing 10 mM K3Fe(CN)6,1 0m M
K4Fe(CN)6, and 0.5% X-gal. Sections were washed and
counterstained with Nuclear Fast Red (Vector Labs; Bur-
lingame, CA). Sections from c-myc
+/+;Alb-Cre
-/-;
ROSA26
+ and c-myc
+/+;Alb-Cre
+;ROSA26
-/- mice served
as negative controls.
b-galactosidase analyses
b-gal ELISA assays were performed using a kit obtained
from Roche (Indianapolis, IN). Briefly, livers were
obtained from 6-8 week old c-myc
fl/fl; Alb-Cre;ROSA26
mice and homogenized by hand using a ground glass
homogenizer with 2 ml 1× Lysis buffer (Roche) per 40
mg tissue. Samples were incubated for 30 min at room
temperature and centrifuged at 13,000 rpm for 15 min
at 4°C. Samples were split into aliquots and frozen in
dry ice/ethanol before transferring to -80°C. An aliquot
was used to determine the protein concentration using
the bicinchoninic acid method (Pierce; Rockford, IL). b-
gal ELISA assays were performed according to the man-
ufacturer’s directions using 5 μg of liver homogenate.
Statistical analyses
Statistical analyses were performed using GraphPad
Prism (San Diego, CA). One-way ANOVA with a post
hoc Bonferroni Multiple Comparison test was per-
formed for comparing the relative abundance of the c-
myc
fl allele by qPCR. Comparisons of the relative abun-
dances of c-myc and cre expression in mice of various
genotypes were performed using a Mann-Whitney test.
A Spearman rank correlation test was performed to
assess the association between c-myc and cre abundance.
For results where differences were not significant, no p
value is reported.
Results
Deletion of hepatic c-myc
Deletion of murine c-myc by gene targeting results in
embryonic lethality at embryonic day 9-10 [23]. In order
to assess the functional role of c-Myc in adult mouse
liver, we utilized a transgenic mouse line where Cre
recombinase is under the control of the Albumin pro-
moter [18]. Conditional deletion of c-myc was achieved
by crossing these mice with c-myc
fl/fl mice. The F1 gen-
eration was intercrossed to obtain c-myc
fl/fl;Alb-Cre
+
and littermate control mice (c-myc
fl/fl;Alb-Cre
-/-, c-myc
+/+;Alb-Cre
+). The c-myc
fl/fl;Alb-Cre
+ and c-myc
+/+;Alb-
Cre
+ lines were also bred to be homozygous for the Cre
transgene. Litters contained the expected frequency of
control and experimental animals.
Cre-mediated recombination of the c-myc locus was
assessed using a qPCR strategy. Primers (XY) were
designed to amplify a region of the c-myc locus
upstream of the 5’ loxP site. A second primer pair (NB)
was designed surrounding the 3’ loxP site such that
Cre-mediated recombination of the locus would result
in a decrease of the NB qPCR product (Figure 1A).
Results revealed a significant decrease in the relative
abundance of the NB product compared to the XY pro-
duct in conditional knockout animals, indicating recom-
bination of the c-myc locus.
By one month of age, recombination approached
70% in both male and female c-myc
fl/fl;Alb-Cre
+
expressing mice, while recombination in c-myc
fl/fl;Alb-
Cre
+/+ mice was significantly higher (Figure 1A).
Sanders et al. BMC Physiology 2012, 12:1
http://www.biomedcentral.com/1472-6793/12/1
Page 3 of 15Consistent with previous findings on the temporal
expression of the Albumin-Cre transgene [24], a simi-
lar deletion efficiency was observed in 8 and 10 week
old conditional knockout animals, indicating that max-
imal recombination had been reached by one month
of age. Since hepatocytes make up approximately 85%
of the total cell population in liver, we estimated that
recombination of the c-myc locus was near 80% in c-
myc
fl/fl;Alb-Cre
+ and over 90% in myc
fl/fl;Alb-Cre
+/+
mice.
Figure 1 Hepatic c-myc deletion in c-myc
fl/fl;Alb-Cre expressing mice. A. Schematic representation of the c-myc
fl allele showing location of
primer pairs used in qPCR analyses to determine the relative abundance of the c-myc
fl allele. The graph shows the quantification of the c-myc
fl
allele in liver from male and female c-myc
fl/fl;Alb-Cre
-/- (open bars), c-myc
fl/fl;Alb-Cre
+ (closed bars) and c-myc
fl/fl;Alb-Cre
+/+ (hatched bars) mice as
described in the Methods. Data are shown as the mean + 1 SD. *, P < 0.01 c-myc
fl/fl;Alb-Cre
+ versus c-myc
fl/fl;Alb-Cre
-/- . **, P < 0.001 c-myc
fl/fl;Alb-
Cre
+ compared to c-myc
fl/fl;Alb-Cre
+/+. B. Hepatic c-myc expression in male and female control and c-myc
fl/fl;Alb-Cre expressing mice as analyzed
by RT-qPCR. Data are shown as individual points with the mean. ◊, c-myc
fl/fl;Alb-Cre
-/-; ▲, c-myc
+/+;Alb-Cre; ○, c-myc
fl/fl;Alb-Cre. *, P = 0.001 4 wk c-
myc
fl/fl;Alb-Cre vs. controls; **P = 0.0004 8 wk c-myc
fl/fl;Alb-Cre vs. controls; ***P = 0.0028 10 wk c-myc
fl/fl;Alb-Cre vs. controls.
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tion on c-myc mRNA, RT-qPCR was performed on total
RNA isolated from livers obtained from control (c-myc
+/+;Alb-Cre
+/+, c-myc
fl/fl;Alb-Cre
-/-) and c-myc
fl/fl;Alb-Cre
+/+ mice at 4, 8, and 10 weeks of age (Figure 1B). A 75%
reduction in c-myc expression in livers from c-myc
fl/fl;
Alb-Cre
+/+ male and female mice was observed at one
month of age and this reduction in c-myc expression
remained stable in the liver through 10 weeks of age.
We assessed the effect of the model on c-Myc protein
levels by immunoprecipitating c-Myc from total liver
homogenates prepared from 4 week old c-myc
fl/fl;Alb-
Cre
+/+ and c-myc
+/+;Alb-Cre
+/+ mice (data not shown).
c-Myc protein content was low in four week old c-myc
+/+;Alb-Cre
+/+ control mice and below the level of
detection in c-myc
fl/fl;Alb-Cre
+/+ mice.
Characterization of hepatic c-myc knockout mice
Our prior studies in the rat showed that c-Myc protein
was expressed in quiescent adult hepatocytes, suggesting a
functional role for the protein in adult liver other than its
role in proliferation [16]. Given the established role of c-
myc in hepatic proliferation and growth, we measured
liver weight to carcass weight ratios in male and female c-
myc
fl/fl;Alb-Cre
+,c - m y c
fl/fl;Alb-Cre
+/+ and control mice
from one month of age through the first year of life. Liver
weight to carcass weight ratios were similar in c-myc
fl/fl
Alb-Cre expressing and control mice at all ages analyzed
(Figure 2). Despite the increased recombination of the c-
myc locus in c-myc
fl/fl;Alb-Cre homozygous mice, no dif-
ference in liver weight was observed in these animals com-
pared to c- myc
fl/fl;Alb-Cre hemizygous mice.
c-Myc has been shown to regulate genes involved in glu-
cose metabolism and to be involved in the regulation of
cell and nucleolar size [12,25]. In order to determine if
loss of c-Myc would result in alterations in glucose home-
ostasis we analyzed serum glucose levels in fed c-myc
fl/fl
and c-myc
+l+ Alb-Cre expressing mice at 4 and 8 weeks of
age. Serum glucose was unaffected in the c-myc
fl/fl;Alb-Cre
expressing mice at both ages (277 ± 19 vs. 271 ± 73.6 and
305 ± 27 vs. 295 ± 20; 4 and 8 weeks respectively).
To investigate whether the organization of the liver
parenchyma or hepatocyte morphology was affected in
c-myc conditional knockout mice, hematoxylin and
Figure 2 Liver weight to carcass weight ratio in c-myc
fl/fl;Alb-Cre expressing mice. Liver:carcass weight ratio was determined for control
and c-myc
fl/fl;Alb-cre male and female mice at various ages. Data are expressed as mean + 1 SD. n ≥ 3 mice/group. Open bars, c-myc
fl/fl;Alb-Cre
-/-;
Black bars, c-myc
+/+;Alb-Cre
+; Hatched bars, c-myc
fl/fl;Alb-Cre
+; Stippled bars, c-myc
fl/fl;Alb-Cre
+/+.
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fl/fl;
Alb-Cre expressing and control mice at 4, 8, and 10
weeks of age (data not shown). The gross and histologi-
cal appearance of the liver were similar in c-myc
fl/fl;Alb-
Cre expressing and control animals as well as c-myc
fl/fl;
Alb-cre hemizygous compared to homozygous animals.
c-myc
fl/fl;Alb-Cre expressing hepatocyte response to
nonproliferative and proliferative stimuli
We extended our studies to determine the effect of
reducing c-Myc in a nonproliferative model of liver
growth, refeeding after a 48 hr fast. Previous studies in
our laboratory have shown that rat liver growth during
refeeding requires rapid and marked induction of ribo-
somal biogenesis and translation initiation, two pro-
cesses where c-Myc has been proposed to have a
functional role [26]. Eight week old c-myc
fl/fl and c-myc
+l+ Alb-Cre expressing mice of both sexes were divided
into three groups. Mice were either fed ad libitum (con-
trol), fasted for 48 hr, or refed ad libitum for 24 hr fol-
lowing a 48 hr fast (refed). As no difference in liver
weight to carcass weight ratio or total liver protein was
observed in c-myc
fl/fl animals carrying one or two alleles
of the Alb-Cre transgene, the data from these animals
were combined. In agreement with our previous data in
the rat [26], fasting for 48 hr resulted in a slight reduc-
tion in liver to carcass weight ratio in both control and
c-myc
fl/fl Alb-Cre expressing animals. Refeeding for 24
hr resulted in restoration of liver weight to carcass
weight ratio to the level of the control fed mice in both
c-myc
fl/fl and c-myc
+l+ animals (Figure 3A). Total liver
protein decreased by approximately 40% in both geno-
types with fasting. Recovery of total protein was attained
a f t e r2 4h ro fr e f e e d i n gi nb o th genotypes, suggesting
that full expression of c-myc is not required for protein
synthesis in this model of liver growth (Figure 3B).
Quiescent adult hepatocytes rapidly enter the cell
cycle in response to a reduction in liver mass. Upregula-
tion of c-Myc protein content is an early event in this
process, suggesting the hypothesis that liver regeneration
following partial hepatectomy requires c-Myc [11,15].
To test this hypothesis, eight to ten-week old male c-
myc
+l+ and c-myc
fl/fl Alb-Cre expressing animals under-
went 2/3 partial hepatectomy. Mice were sacrificed 24,
48, or 96 hr post-hepatectomy. Liver weight to carcass
weight ratios were determined (Figure 4A). No differ-
ence in liver to carcass weight ratio between c-myc
fl/fl;
Alb-Cre expressing and control mice was observed at
any of the timepoints analyzed. However, a slight
decrease in the number of Ki-67 positive hepatocytes
was observed in the c-myc
fl/fl mice compared to wild-
type mice 48 hr post-hepatectomy (Figure 4B). To deter-
mine if cells lacking in c-myc were responsible for liver
regeneration, we quantified c-myc deletion in each
mouse in the regenerated liver and liver excised at the
time of partial hepatectomy. We found that the regener-
ating liver was as deficient in the c-myc allele as was the
liver excised at the time of surgery [average fold change
(0.84 ± 0.82; 0.80 ± 0.93; 0.78 ± 0.86) 24, 48, 96 hr,
respectively]. The persistent loss of the c-myc allele was
consistent with the conclusion that the recovered liver
mass was arising from c-myc-deficient cells. Despite any
modest decrease in the number of hepatocytes in the
cell cycle, the absence of an effect on the recovery of
liver weight indicates that the liver is capable of regen-
eration despite a significant reduction in c-myc.A si n
the non-proliferative model, there was no difference in
mice containing one versus two alleles of the Alb-Cre
transgene. Liver sections obtained from mice placed on
the fasting/refeeding protocol and from animals sub-
jected to 2/3 partial hepatectomy did not reveal disorga-
nization of the liver parenchyma or any other obvious
changes in hepatocyte morphology between c-myc
fl/fl
and c-myc
+l+ Alb-Cre expressing mice (Figure 5).
Expression of members of the c-myc/max/mad network
We went on to explore whether the lack of an effect of
reducing c-myc on hepatocyte proliferation, growth, and
protein synthesis could be accounted for by compensa-
tory induction of other myc family members or the c-
Myc binding partner Max. We had previously found
that max expression at both the RNA and protein level
correlated with hepatocyte proliferation during rat liver
development and that overexpression of max induced a
shift in c-Myc localization from the nucleolus to the
nucleus [15]. These data raise the possibility that com-
pensatory induction of Max could increase c-Myc activ-
ity. Multiplex RNase protection assays were performed
on total RNA isolated from 8 and 10 week old c-myc
fl/fl
and c-myc
+l+ Alb-Cre expressing animals of both sexes
(Figure 6). Two of the myc family members, B-myc and
L-myc were expressed in murine liver, while N-myc
expression was below the level of detection in our assay.
There was no difference in the expression of these
family members or of max in c-myc
fl/fl compared to
wild-type c-myc Alb-Cre expressing mice.
There is substantial overlap between the role of c-Myc
and Wnt/b-catenin signaling in the regulation of postna-
tal liver development, hepatic organization, and liver
regeneration [27]. In addition, c-myc is a downstream
target of b-catenin [28]. Given the interaction between
c-myc and b-catenin, we investigated whether deletion
of c-myc is compensated by upregulation of b-catenin
signaling. Immunohistochemical analysis for b-catenin
was performed on liver sections from wild-type and c-
myc deficient mice. No difference in the localization of
b-catenin was observed between the two genotypes of
mice. These results were confirmed by Western
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prepared from liver of wild-type and c-myc deficient
mice (data not shown).
Effect of c-myc
fl/fl on Cre expression
Numerous studies using the Alb-Cre transgene to delete
various genetic loci involved in hepatocyte proliferation,
growth, and survival have reported recombination nearing
100% and complete ablation of the expression of the gene
of interest [29-31]. Given our results, which varied mark-
edly from published experience, we investigated the
expression and activity of the Alb-Cre transgene in c-myc
+/+ and c-myc
fl/fl mice to ascertain whether floxing c-myc
had an effect on the expression of the Alb-Cre transgene
such that c-myc deletion would be impaired in our model.
RNA was isolated from livers obtained from c-myc
+/+;Alb-
Cre
+/+ and c-myc
fl/fl;Alb-Cre
+/+ a n i m a l sa t4 ,8 ,a n d1 0
weeks of age. RT-qPCR was performed to assess cre
Figure 3 Effect of conditional c-myc deletion on liver growth following starvation. Male and female mice were fed ad libitum (control),
fasted for 48 hr (fasted), or fasted for 48 hr then refed ad libitum for 24 hr (refed). A. The graph shows liver:carcass weight ratios for c-myc
+/+
(open bars) and c-myc
fl/fl (closed bars) Alb-Cre expressing mice expressed as the mean + 1 SD. n ≥ 3 mice/group. B. Liver homogenates were
prepared and protein concentration determined using the bichoninic acid method. Total liver protein was then calculated based on total liver
weight. The graph shows total liver protein content for c-myc
+/+ (open bars) and c-myc
fl/fl (closed bars) Alb-Cre expressing mice expressed as the
mean + 1 SD. n ≥ 3 mice/group.
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Page 7 of 15Figure 4 Effect of conditional c-myc deletion on liver regeneration. Male mice were subjected to 2/3 hepatectomy and assessed 24, 48, or
96 hr after resection. A. The graph shows liver:carcass weight ratio for c-myc
+/+ (open bars) and c-myc
fl/fl (closed bars) Alb-Cre expressing mice.
The data are expressed as the mean + 1 SD. n ≥ 3 mice/group. B. Hepatocyte proliferation in duplicate c-myc
+/+ and c-myc
fl/fl Alb-Cre expressing
mice 48 hr post-hepatectomy as assessed by Ki-67 immunohistochemistry. Representative 20× images are shown.
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Page 8 of 15expression (Figure 7A). A statistically significant difference
in cre expression was observed in c-myc
fl/fl compared to c-
myc
+/+ mice at 4 weeks of age suggesting that deletion of
c-myc suppressed expression of the Alb-Cre transgene. At
8 and 10 weeks of age there was no statistically significant
difference in cre expression between c-myc
fl/fl and c-myc
+/+ mice. However, in comparison to 4-week old animals,
cre expression in older mice varied considerably from ani-
mal-to-animal.
To ascertain whether the variation in cre expression
correlated with the amount of c-myc we compared the
relative abundance of cre and c-myc in individual c-
myc
fl/fl;cre
+/+ mice at 4, 8, and 10 weeks (Figure 7B).
This analysis revealed a significant association between
floxing c-myc and the expression of cre (Spearman r =
-0.6609, p = 0.0019).
We further characterized the pattern of Cre activity in
our model by crossing our mice to the ROSA26 reporter
line. The ROSA26 line has a lacZ gene that is expressed
when an upstream stop codon is removed by Cre-
mediated recombination. In order to study the effect of
floxing c-myc on Cre activity, mice were further crossed
to obtain c-myc
fl/fl;Alb-Cre;ROSA26 and c-myc
+/+;Alb-
Cre;ROSA26 mice. Sections prepared from six-week old
mice were stained for b-galactosidase activity using X-
gal. Analysis revealed a wide pattern of LacZ-staining
across 20× fields of individual sections in both geno-
t y p e so fm i c e( F i g u r e8 ) .I ns o m ef i e l d s ,t h em a j o r i t yo f
the hepatocytes displayed intense nuclear and cytoplas-
mic staining while other hepatocytes exhibited weak
cytoplasmic staining. There were also fields where many
of the hepatocytes appeared negative for Lac-Z staining.
Figure 5 Effect of conditional c-myc deletion on parenchymal organization during fasting/refeeding and liver regeneration. Formalin
fixed liver from male and female mice was processed and stained with H&E. Slides were scanned with an Aperio Scanscope CS and randomly
selected representative areas with a scan zoom of 20 were acquired. A. Images (20×) obtained from control, 48 hr fasted, and 48 hr fasted
followed by 24 hr refeeding c-myc
+/+ and c-myc
fl/fl Alb-Cre expressing mice. B. Representative 20× images from c-myc
+/+ and c-myc
fl/fl Alb-Cre
expressing mice 24, 48, or 96 hr post-hepatectomy.
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Page 9 of 15Figure 6 Expression of members of the c-myc/max/mad network in liver derived from male and female control and c-myc conditional
knockout mice. Total liver RNA was isolated from triplicate c-myc wild-type (open bars) and c-myc
fl/fl (closed bars) Alb-Cre expressing mice at 8
and 10 weeks of age and a multiprobe RNase protection assay performed. Expression levels of B-myc, L-myc, and max were quantified and
normalized to the internal control L32. Data are expressed as mean + 1 SD.
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Page 10 of 15In light of the qualitative nature of the Lac-Z staining,
we prepared liver homogenates from 6-8 week old mice
and performed b-gal ELISA assays in order to quantitate
Cre activity (data not shown). No difference in B-gal
content was found in the c-myc
fl/fl;Alb-Cre;ROSA26 ver-
sus the c-myc
+/+;Alb-Cre;ROSA26 controls.
Discussion
The transcription factor c-Myc has long been assigned a
prominent role in the synchronous hepatocyte prolifera-
tion that occurs during liver regeneration [9,11]. A ser-
ies of in vivo studies performed in our laboratory
characterizing the regulation of the c-myc/max/mad
Figure 7 Cre expression in c-myc conditional knockout and control mice. A. Total liver RNA was isolated from male and female c-myc
+/+;
Alb-Cre
+/+ (▲) and c-myc
fl/fl;Alb-Cre
+/+ (○) mice and cre expression assessed using RT-qPCR. Data are shown as individual points with the mean. *,
P = 0.0303 4 wk c-myc
fl/fl;Alb-Cre
+/+ vs control. B. The correlation between cre expression and c-myc abundance in c-myc
fl/fl;Alb-Cre
+/+ expressing
mice at 4, 8 and 10 weeks of age. Data are expressed as individual points. ◊, 4 weeks; ▲, 8 weeks; ○, 10 weeks.
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Page 11 of 15network in fetal and adult liver revealed that c-Myc was
present in quiescent adult hepatocytes and was localized
to the nucleolus [16]. These studies led us to hypothe-
s i z eaf u n c t i o n a lr o l ef o rc - M y ci na d u l tl i v e rt h a tw a s
independent of its role in proliferation. In order to test
this hypothesis, we generated a conditional knockout
using floxed c-myc and Albumin-Cre mice. This
approach led to significant reduction in c-myc expres-
sion one month after birth in c-myc
fl/fl;Alb-Cre expres-
sing mice. We observed greater recombination efficiency
in c-myc
fl/fl;Alb-Cre homozygous compared to
hemizygous animals. However, there was no difference
in liver weight ratios during development in c-myc
fl/fl;
Alb-Cre
+/+ compared to c-myc
fl/fl;Alb-Cre
+ animals. As
we did not observe differences in these two groups in
regards to histology, liver regeneration or the recovery
from fasting, the animals were grouped together for
comparison with c-myc wild-type Alb-Cre expressing
mice. There was a low level of residual c-myc that per-
sisted in c-myc
fl/fl;Alb-Cre expressing livers even up to
four months. This residual level may be a result of
expression in nonparenchymal cells or a subset of
Figure 8 Cre activity in c-myc conditional knockout and control mice. Cre expressing c-myc
+/+ and c-myc
fl/fl mice were crossed to mice
carrying the Rosa26R allele to obtain c-myc
+/+;Rosa;Alb-Cre and c-myc
fl/fl;Rosa;Alb-Cre mice. Liver cyrosections (10 μm) from male and female mice
were fixed and stained for Lac-Z. Photomicrographs of three 20× fields from individual sections acquired from c-myc
+/+;Rosa;Alb-Cre and c-myc
fl/fl;
Rosa;Alb-Cre mice are shown. All panels show images that are representative of the results obtained on multiple sections from at least 2 animals
per group. The results were replicated in a duplicate experiment. The contrast was adjusted across the entire image to accurately reflect the
appearance of the sections under the microscope.
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Page 12 of 15hepatocytes in which the albumin promoter is not
expressed. However, we were unable to exclude a low
level of c-myc expression in the larger population of
hepatocytes. Interestingly, floxed c-myc had an inhibi-
tory effect on Cre expression in one month old mice. In
contrast, in older animals Cre expression was extremely
variable regardless of c-myc status. This variation may
be a result of age-dependent silencing of the Cre
transgene.
Variegation of transgene expression is a well docu-
mented phenomenon in many lines of transgenic mice
[32-34] although the cause and mechanism is not
known. In a mouse model where lacZ was driven by the
b-globin promoter, there was a general tendency of
decreased transgene expression with age [35]. In con-
trast to other reports on variable transgene expression,
we observed a negative effect of our floxed gene on Cre
recombinase expression. We speculate that this effect is
a result of a selective pressure to retain c-myc in hepato-
cytes. It is possible that this selective effect could mani-
fest itself in ways other than an effect on Cre expression.
There was no apparent phenotypic effect of signifi-
cantly reducing c-myc in hepatocytes. The livers of c-
myc
fl/fl;Alb-Cre expressing and control mice were of
similar size and histology, consistent with the conclusion
that c-myc is not required for hepatocyte proliferation
during normal liver growth and maintenance. We used
two models, partial hepatectomy and liver growth fol-
lowing refeeding to determine c-Myc function in the
presence or absence of a proliferative stimulus. c-Myc
has been considered to have a prominent role in the
hepatocyte proliferation that occurs during liver regen-
eration. After partial hepatectomy there was a slight
decrease in the number of hepatocytes in the cell cycle
at 48 hr. However, no delay in the restoration of liver
mass was observed, indicating that c-myc is not required
for liver regeneration following 2/3 partial hepatectomy.
While these studies were in progress, two conflicting
reports were published on the effect of deleting c-myc
on liver regeneration. Baena et al. found that deletion of
c-myc resulted in impaired liver regeneration [36]. How-
ever, Li et al. reported a total restoration of liver mass
by 7 days post-resection in mice where floxed c-myc
was deleted using adenoviral Cre [37]. In contrast to our
study and Li et al., where liver/body mass ratio was used
as the outcome measurement for liver regeneration,
Baena et al. used PCNA and Cyclin A content as an
indirect measure of hepatocyte proliferation. Further-
more, the content of these proteins was only determined
2 day post-hepatectomy leaving it unclear whether liver
regeneration would have been affected at later time
points. Taken together, these studies indicate that c-myc
is not essential for restoration of liver mass during
regeneration.
In some systems, changes in c-myc content affect cell
size without affecting cell proliferation [38]. In order to
assess the function of c-Myc in a non-proliferative
model of hepatocyte growth, mice were fasted for 48 hr
followed by a 24 hr refeeding period. In accordance
with our published data in the rat, a 48 hr fast resulted
in decreased liver/body mass ratio and liver protein con-
tent while refeeding resulted in restoration of liver mass
and protein despite a significant reduction in c-myc.c -
Myc has been proposed to play a role in essential pro-
cesses leading to hepatocyte growth, such as, ribosomal
biogenesis and protein synthesis. Kim et al found that
transient c-myc overexpression in mouse liver led to
hepatocyte hypertrophy, the induction of ribosomal
genes, and increased protein synthesis [12]. Our results
indicate that protein synthesis and hepatocyte growth
can occur in spite of a significant reduction in c-myc,
raising the notion that overexpression of c-Myc may
result in the activation of gene regulatory networks and
pathways not normally controlled by c-Myc in adult
hepatocytes.
Studies by Murphy et al. led to the conclusion that the
level of c-myc expressed in a cell is crucial to its biologi-
cal effect [39]. These studies used a mouse model where
the activation of Cre recombinase results in the expres-
sion of a tamoxifen inducible MycER fusion protein
with the amount of c-Myc expressed dependent on
whether the mouse carried one or two MycER alleles.
The authors report that modest increases in c-Myc can
activate cellular proliferation while a higher threshold is
needed to stimulate apoptosis. This study suggests that
a high level of c-Myc may lead to the binding of a dif-
ferent set of target genes from those regulated by endo-
genous levels of c-Myc. This notion is further supported
by studies on the role of c-Myc in hepatocarcinogenesis.
Deregulation of c-Myc through gains in copy number,
point mutations, and transactivation by viral proteins is
observed in 30-60% of human hepatocellular carcinomas
(HCC) [40,41]. Although its role in the development of
human HCC is unclear, studies in transgenic mice have
shown that overexpression of this oncogene results in
increased hepatocyte proliferation, genomic instability
and apoptosis. The paradoxical activation of cellular
proliferation and growth in concert with apoptosis leads
to the requirement of secondary mutations for tumor
development [42,43].
Our studies do not rule out a subtle effect of delet-
ing c-myc on other aspects of liver physiology. It is
possible that c-myc deletion affects other pathways. c-
Myc has been shown to regulate many genes involved
in liver metabolism and can ameliorate the effects of
diabetes on glucose metabolism in mice [25,44].
Regardless of potential effects on other pathways
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Page 13 of 15overall adult liver physiology appeared to be unaffected
by c-myc deletion.
Studies performed to assess the requirement and func-
tion of c-Myc in other mature tissues suggest that the
role of this protein in proliferation, growth, and other
cellular processes is cell-type dependent. Deletion of c-
myc in the hematopoietic lineage results in defective
hematopoiesis and angiogenesis leading to embryonic
lethality while there was no requirement for c-myc in
endothelial cells [45]. Moreover, normal adult intestinal
homeostasis occurs in the absence of c-myc, yet c-myc is
required for the formation of intestinal crypts [46].
These studies lead to the conclusion that the in vivo tar-
gets of c-myc will vary based on cell type and develop-
mental stage thus adding another layer of complexity to
understanding the functional role of c-myc.
Conclusions
Our studies indicate that a reduction in hepatic c-myc
d o e sn o ta f f e c tn o r m a lp o s t n a t a ll i v e rg r o w t ha n d
development. Furthermore, reducing this proto-onco-
gene does not affect the restoration of liver mass dur-
ing liver regeneration or the restoration of liver
protein following fasting. However, our studies do not
rule out subtle effects of c-myc on liver metabolism or
liver physiology. Decreasing c-myc correlated with a
reduction in the expression of the Albumin-Cre trans-
gene, suggesting a selective pressure to maintain c-
myc. Furthermore, this pressure may prevent the com-
plete deletion of hepatic c-myc by traditional condi-
tional knockout strategies.
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